Vivos Therapeutics, Inc. Contract with Customer, Receivable, after Allowance for Credit Loss
Vivos Therapeutics, Inc. (VVOS) had Contract with Customer, Receivable, after Allowance for Credit Loss of $1.40 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Revenue from Contract with Customer › Contract with Customer, Receivable, after Allowance for Credit Loss
us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss · last filed 2026-08-14
- 2026-06-30: Contract with Customer, Receivable, after Allowance for Credit Loss $1.40M.
- 2026-03-31: Contract with Customer, Receivable, after Allowance for Credit Loss $1.80M.
- 2025-12-31: Contract with Customer, Receivable, after Allowance for Credit Loss $1.60M.
- 2025-09-30: Contract with Customer, Receivable, after Allowance for Credit Loss $2.10M.
| Period end | Contract with Customer, Receivable, after Allowance for Credit Loss |
|---|---|
| 2026-06-30 | $1.40M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.80M 10-Q · filed 2026-05-20 |
| 2025-12-31 | $1.60M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $2.10M 10-Q · filed 2025-11-19 |
| 2024-12-31 | $400.00K 10-K · filed 2026-04-15 |
| 2024-01-01 | $200.00K 10-K · filed 2026-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |